Halozyme Therapeutics Non-GAAP EPS of $1.72 beats by $0.11, revenue of $354.3M beats by $15.2M (NASDAQ:HALO)

Group 1 - The article discusses the importance of enabling Javascript and cookies in browsers to prevent access issues [1] - It highlights that users with ad-blockers may face restrictions when trying to access content [1]